The United States Pharmacopeia today notified stakeholders that it is postponing the official effective dates of several new and revised standards pertaining to pharmaceutical handling until further notice while it reviews appeals to the standards. Those standards include general chapters <795> (Pharmaceutical Compounding – Nonsterile Preparations), <797> (Pharmaceutical Compounding – Sterile Preparations), and <825> (Radiopharmaceuticals – Preparation, Compounding, Dispensing, and Repackaging). In addition, due to the pending appeals, USP new general chapter <800> (Hazardous Drugs Handling in Healthcare Settings) will remain official, but only informational and will not be applicable until the appeals process is complete. The AHA in November 2018 urged USP to delay the official dates of both USP <797> and <800> due to expedited implementation and compliance concerns.

Related News Articles

Headline
In a new “Safety Speaks” conversation, Harry S. Smith, board chair of Valley Health System and member of the AHA Committee on Governance, discusses how Valley…
Headline
“Safety Speaks” is a new Advancing Health series where hospital and health system leaders share successes from their organizations’ patient safety efforts. In…
Blog
The Meharry School of Global Health is the realization of a promise made by Meharry Medical College almost 150 years ago — a promise born out of the legacy of…
Headline
As part of Community Health Improvement Week June 10-14, the AHA released a video showcasing the impact Indiana University Health's iHEART collaborative has…
Headline
The AHA announced June 5 that Main Line Health in Radnor, Pa., Augusta Health in Fishersville, Va., and AnMed in Anderson, S.C., are the three honorees for…
Headline
The Food and Drug Administration last week granted enforcement discretion for the use of conjunctival swabs by laboratories as part of human testing for H5N1…